HomeInsights52 Week Low Stocks

Parenteral Drugs (india) Ltd 52 Week Low

Parenteral Drugs (india) Ltd 52 Week Low

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Aug 21, 2023)

stocks purchased

1.3 K

Stocks Traded

(Aug 21, 2023)

Last Updated on: Nov 15, 2024

Image

Parenteral Drugs (India) Ltd

NSE: PDPL

YEARLOW

₹ -

Last updated on: Aug 21, 2024

Key Highlights

  • The 52 Week Low of Parenteral Drugs (India) Ltd is ₹ 0 as of 21 Aug 23.

Company Fundamentals for Parenteral Drugs (India) Ltd

No data available

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Parenteral Drugs (India) Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Aug 20233.39
14 Aug 20233.24
24 Jul 20233.09
17 Jul 20233.25
10 Jul 20233.42
03 Jul 20233.59
26 Jun 20233.77
19 Jun 20233.96
12 Jun 20233.85
05 Jun 20234.05

Asset Value vs Market Value of Parenteral Drugs (India) Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Historical Net Profit of Parenteral Drugs (India) Ltd

No data available

* All values are in crore

Parenteral Drugs (India) Ltd News Hub

News

Parenteral Drugs (India) to conduct board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 3...

Read more

19 May 202215:25

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

05 Feb 202215:19

News

Parenteral Drugs (India) to convene EGM

Parenteral Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Com...

Read more

03 Feb 202216:49

News

Parenteral Drugs (India) schedules board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 2...

Read more

31 Jan 202211:36

News

Parenteral Drugs (India) to hold board meeting

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 1...

Read more

06 Nov 202116:34

News

Parenteral Drugs (India) AGM scheduled

Parenteral Drugs (India) announced that the 37th Annual General Meeting (AGM) of the compa...

Read more

27 Aug 202114:27

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Parenteral Drugs (India) Ltd

Why is it important to track the 52-week low of Parenteral Drugs (India) Ltd stocks?

Investors should monitor the 52-week low of Parenteral Drugs (India) Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Parenteral Drugs (India) Ltd stocks hitting a 52-week low?

Factors leading to Parenteral Drugs (India) Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Parenteral Drugs (India) Ltd stocks when they hit a 52-week low?

Buying Parenteral Drugs (India) Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Parenteral Drugs (India) Ltd stocks?

Investors should monitor the 52-week low of Parenteral Drugs (India) Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Parenteral Drugs (India) Ltd stock at their 52-week low?

An investor can analyze the reasons for the Parenteral Drugs (India) Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Parenteral Drugs (India) Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Parenteral Drugs (India) Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Parenteral Drugs (India) Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*